Express Scripts Value-Based Program To Leverage Generic Advair

Pharmacy benefit manager Express Scripts plans to shake up the asthma/pulmonary and multiple sclerosis categories in 2018 with new contracting programs.

CrackedEggs_1200x675

Pharmacy benefit manager Express Scripts Holding Co. will roll out a value-based purchasing program in 2018 in the pulmonary drug category that will leverage the competition offered by an expected generic version of GlaxoSmithKline PLC's Advair Diskus (fluticasone/salmeterol) to lower costs.

"Our clients are clamoring from some reprieve from Advair in asthma, pulmonary conditions. So that will be the cornerstone of...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access